Vascular endothelial growth factor and social support in patients with ovarian carcinoma

Cancer

Volumn 95, Issue 4, 2002, Pages 808-815

  Lutgendorf, Susan K ^a   Johnsen, Erica L ^a   Cooper, Brian ^b   Anderson, Barrie ^b   Sorosky, Joel I ^b   Buller, Richard E ^b   Sood, Anil K ^b  

^a University of Iowa   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Ovarian carcinoma; Psychoneuroimmunology; Social support; Tumor angiogenesis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MENTAL STRESS; OVARY CARCINOMA; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; SOCIAL SUPPORT; SYMPATHETIC TONE; TUMOR GROWTH; WELLBEING;

ADULT; AGED; CARCINOMA; DEPRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MIDDLE AGED; OVARIAN NEOPLASMS; QUALITY OF LIFE; SOCIAL SUPPORT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037102943     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10739     Document Type: Article

References (67)

1. Stress and immune responses after surgical treatment for regional breast cancer
2. Endocrine and cytokine correlates of major depression and dsythymia with typical or atypical features
3. Depression and immunity: A metaanalytic review
4. Stress and immunity in humans: A meta-analytic review
5. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging
6. Stress-related changes in proinflammatory cytokine production in wounds
7. Impairment of lymphocyte activities in depressed aged subjects
8. Stress, cytokine patterns and susceptibility to disease
9. Immune correlates of depression
10. Life stress, mood disturbance, and elevated IL-6 in healthy older women
11. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: Differential effects and pathways
12. Social support and immune function among spouses of cancer patients
13. Marital stress: Immunologic, neuroendocrine, and autonomic correlates
14. The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health
15. Stressful personal relationships: Endocrine and immune function
16. Catecholamines, sympathetic nerves, and immunity
17. The hypothalamic-pitiutiary-adrenal axis and immune-mediated inflammation
18. Bidirectional effects of stress and glucocorticoid hormones on immune function: Possible explanations for paradoxical observations
19. Opioidergic modulation of the immune system
20. Growth hormone and insulin-like growth factor as cytokines in the immune system
21. Psychological stress, immunity, and cancer
22. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures
23. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity
24. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats
25. What is the evidence that tumors are angiogenesis dependent?
26. Tumor angiogenesis: Past, present, and the near future
27. Tumor angiogenesis
28. In vivo assessment of vascular endothelial growth factor-induced angiogenesis
29. Proinflammatory mediators stimulate neutrophil-directed angiogenesis
30. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma
31. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
32. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
33. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
34. Vascular endothelial growth factor expression in early stage ovarian carcinoma
35. Preoperative serum vascular endothelial growth factor (VEGF) levels: Significance in ovarian cancer
36. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cells interactions in multiple myeloma
37. The expression of transforming growth factor-beta-1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma
38. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with extrogen-induced increases in uterine capillary permeability and growth
39. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
40. Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats
41. Adrenergic activation of vascular endothelial growth factor mRNA expression in rat brown adipose tissue: Implication in cold-induced angiogenesis
42. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2
43. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
44. Interleukin-6 and social support in gynecologic cancer patients
45. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission
46. Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of hypothalamic-pituitary-adrenal axis
47. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women
48. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
49. Interleukin-6 levels in depressed patients before and after treatment with fluoxetine
50. Stress, social support, and the buffering hypothesis
51. Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality
52. Social relationships and health
53. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS
54. Stress, adaptation and disease. Allostasis and allostatic load
55. Development and validation of the general measure
56. Controlled prospective longitudinal study of women with cancer: II. Sexual functioning outcomes
57. Quality of life and mood in women with gynecologic cancer: A one year prospective study
58. Negative behavior during marital conflict is associated with immunological down-regulation
59. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults
60. Social support and salivary cortisol in women with metastatic breast cancer
61. Psychosocial-immune relationships in HIV disease
62. Social ties and support and neuroendocrine function: The MacArthur studies of successful aging
63. Impact of social environment characteristics on neuroendocrine regulation
64. Cognitive behavioral stress management reduces anxiety and 24-hour urinary catecholamine output among symptomatic HIV-infected gay men
65. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men
66. A biobehavioral model of cancer stress and disease course